Skip to Main Content

Explore Our Publications

Entrada’s commitment to publications & transparency

Entrada is committed to publishing the results of our sponsored research in a transparent, scientifically accurate, and timely manner. Entrada will apply high ethical standards to our publications and presentations and will adhere to recognized industry guidance such as International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals and International Society for Medical Publication Professionals (ISMPP) Good Publication Practice for Communicating Company Sponsored Medical Research.

Upcoming Presentations

  • EEV-mediated Delivery to Satellite Cells: Towards a Comprehensive Correction of Pathophysiology in a Preclinical Model of Duchenne Muscular Dystrophy

  • ELEVATE-44-201, a Phase 1/2b Study to Assess the Safety and Efficacy of ENTR-601-44 in Patients With DMD Amenable to Exon 44 Skipping

    • By: Laurent Servais, MD, PhD, MDUK Oxford Neuromuscular Centre & NIHR Oxford Biomedical Research, University of Oxford, and Neuromuscular Reference Centre, University Hospital of Liège
    • At: 30th Annual Congress of the World Muscle Society
    • On: October 7, 2025
  • ELEVATE-45-201, a Phase 1/2b Study to Assess the Safety and Efficacy of ENTR-601-45 in Patients With DMD Amenable to Exon 45 Skipping

  • Preclinical Efficacy of ENTR-601-50, a Novel EEV™-Oligonucleotide Construct for the Treatment of Exon 50 Skip–Amenable Duchenne Muscular Dystrophy

Past Presentations